{"entity":{"type":"insider","cik":"0001785888","url":"/insider/0001785888","json_url":"/insider/0001785888.json","name":"Wijkstrom Joakim","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2020-08-21","last":"2026-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Wijkstrom Joakim","source":"filing","n_filings":9,"first_seen":"2020-08-21","last_seen":"2026-03-04"}],"transactions":[{"id":5747826,"accession":"0001785888-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001785888-26-000002","line_url":"/filing/0001785888-26-000002#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30800.0,"shares_display":"30,800","price_per_share":8.2659,"price_display":"8.27","price_state":"stated","total_value":254589.72,"total_display":"254,589.72","total_whole":"254,590","shares_owned_after":333469.0,"shares_owned_after_display":"333,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":2175997,"accession":"0000950170-24-027259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-027259","line_url":"/filing/0000950170-24-027259#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9229.0,"shares_display":"9,229","price_per_share":4.2074,"price_display":"4.21","price_state":"stated","total_value":38830.0946,"total_display":"38,830.09","total_whole":"38,830","shares_owned_after":129789.0,"shares_owned_after_display":"129,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":2175992,"accession":"0000950170-24-027259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-027259","line_url":"/filing/0000950170-24-027259#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7498.0,"shares_display":"7,498","price_per_share":4.4133,"price_display":"4.41","price_state":"stated","total_value":33090.9234,"total_display":"33,090.92","total_whole":"33,091","shares_owned_after":139018.0,"shares_owned_after_display":"139,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8704211,"accession":"0001209191-23-047056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047056","line_url":"/filing/0001209191-23-047056#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3724.0,"shares_display":"3,724","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":21748.16,"total_display":"21,748.16","total_whole":"21,748","shares_owned_after":113816.0,"shares_owned_after_display":"113,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":7917738,"accession":"0001209191-23-016463","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-016463","line_url":"/filing/0001209191-23-016463#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4113.0,"shares_display":"4,113","price_per_share":6.32,"price_display":"6.32","price_state":"stated","total_value":25994.16,"total_display":"25,994.16","total_whole":"25,994","shares_owned_after":117540.0,"shares_owned_after_display":"117,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":7917735,"accession":"0001209191-23-016463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016463","line_url":"/filing/0001209191-23-016463#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7720.0,"shares_display":"7,720","price_per_share":6.2335,"price_display":"6.23","price_state":"stated","total_value":48122.62,"total_display":"48,122.62","total_whole":"48,123","shares_owned_after":121653.0,"shares_owned_after_display":"121,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6497361,"accession":"0001209191-22-047210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047210","line_url":"/filing/0001209191-22-047210#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3605.0,"shares_display":"3,605","price_per_share":10.2656,"price_display":"10.27","price_state":"stated","total_value":37007.488,"total_display":"37,007.49","total_whole":"37,007","shares_owned_after":96673.0,"shares_owned_after_display":"96,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-22","filed_date":"2022-08-23","scope":"insider"},{"id":6623435,"accession":"0001209191-22-015158","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015158","line_url":"/filing/0001209191-22-015158#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6974.0,"shares_display":"6,974","price_per_share":11.193,"price_display":"11.19","price_state":"stated","total_value":78059.982,"total_display":"78,059.98","total_whole":"78,060","shares_owned_after":100278.0,"shares_owned_after_display":"100,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-02","scope":"insider"},{"id":5336055,"accession":"0001209191-21-052965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052965","line_url":"/filing/0001209191-21-052965#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3650.0,"shares_display":"3,650","price_per_share":15.3944,"price_display":"15.39","price_state":"stated","total_value":56189.56,"total_display":"56,189.56","total_whole":"56,190","shares_owned_after":74552.0,"shares_owned_after_display":"74,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-20","filed_date":"2021-08-23","scope":"insider"},{"id":4774829,"accession":"0001209191-21-017278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017278","line_url":"/filing/0001209191-21-017278#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3888.0,"shares_display":"3,888","price_per_share":18.4488,"price_display":"18.45","price_state":"stated","total_value":71728.9344,"total_display":"71,728.93","total_whole":"71,729","shares_owned_after":78202.0,"shares_owned_after_display":"78,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider"},{"id":2833350,"accession":"0001209191-20-047991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047991","line_url":"/filing/0001209191-20-047991#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001785888","owner_name":"Wijkstrom Joakim","owner_display_name":"Wijkstrom Joakim","owner_url":"/insider/0001785888","role":"Officer (SVP, Chief Marketing Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Marketing Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Marketing Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3710.0,"shares_display":"3,710","price_per_share":11.0806,"price_display":"11.08","price_state":"stated","total_value":41109.026,"total_display":"41,109.03","total_whole":"41,109","shares_owned_after":56290.0,"shares_owned_after_display":"56,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (SVP, Chief Marketing Officer)","n_filings":9,"first_seen":"2020-08-21","last_seen":"2026-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001785888","retrieved_at":"2026-08-25T23:28:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}